Good morning all. Welcome to today’s conference call to discuss Greenlane Holdings Third Quarter Financial Results. A press release detailing the financial results for the quarter was distributed this morning and is available on the Investor Relations section of the Greenlane website. As a reminder, today’s conference is being recorded. On the call today are Aaron LoCascio, Chief Executive Officer; and Bill Mote, Chief Financial Officer. Before we begin, Greenlane would like to remind listeners that today’s prepared remarks may contain forward-looking statements and management may make additional forward-looking statements in response to the questions received. These statements do not guarantee future performance and therefore, undue reliance should not be placed upon them. These statements are based on current expectations of the Company’s management and involve inherent risks and uncertainties and other factors discussed in today’s press release. This call also contains time-sensitive information that speaks only as of the date of this live broadcast, November 17, 2020. Factors that could cause Greenlane’s results to differ materially are set forth in today’s press release and in Greenlane’s annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC. Any forward-looking statements made today on this call are based on assumptions as of today, and Greenlane assumes no obligation to update these statements as a result of new information or future events. During today’s call, Greenlane management may discuss non-GAAP financial measures including adjusted net loss and adjusted EBITDA. Greenlane has included a reconciliation of these non-GAAP measures in today’s press release, which is available on the Investor Relations section of our website.

Good morning, and thank you, everyone, for joining us today. During this call, I will review our business transformation plan, third quarter sales highlights, operating environments, and business development activities before turning the call over to our Chief Financial Officer, Bill Mote, for a detailed review of our financial results. During the third quarter, our new senior leadership team and I completed an extensive review of our business and acted on several key initiatives related to our going-forward category emphasis, organizational structure, and related staffing levels. We have taken additional decisive steps to deemphasize certain product lines, invest in our fastest-growing and high-margin opportunities, and further improve our cost structure. We remain focused on executing our strategic vision, launching exciting new consumer products, and making the necessary positive changes throughout the organization to maintain Greenlane’s position as the leading platform for cannabis consumption products globally, return to profitability and generate strong shareholder value. The steps we are taking now will reaffirm our strong foundation to capitalize on the anticipated sector growth as existing markets continue to evolve and new markets develop. Our approach is focused on four key pillars: the first focuses on increasing our higher-margin revenue opportunities through our Greenlane branded products and broader assortment. The second is increasing our operational efficiencies by streamlining and optimizing our distribution platform to further reduce costs. The third is to refine our sales approach to drive customer growth. And the fourth is that we will continue to enhance and expand our platform through strategic development as well as carefully selected M&A opportunities. Subsequent to the quarter end, we completed the transition to our new centralized and streamlined distribution model and also reduced worldwide headcount by 4.5%. In combination with other expense reductions, these decisions are expected to generate annualized savings of $5 million by the end of Q1 2020. We saw further proof that our transformation initiatives are being successfully implemented with continued diversification of our revenue mix as well as growth in our high-margin opportunities. Our core revenue grew 36% to $32.3 million in Q3 2020 compared to $23.8 million in Q3 2019. Notably, sales of our Greenlane brands grew 65% to approximately $5.6 million in Q3 2020 or 15.5% of total revenue. B2C increased to 13% for Q3 2020 compared to 3% in Q3 2019. And S&P increased 11% for Q3 2020 compared to 10% in Q3 2019. This focus on higher-margin opportunities and appropriate channel mix will position us for long-term growth. On the product side, subsequent to quarter end, we obtained the exclusive right to expand the availability of Marley Naturals’ accessories to specialty locations in Central and South America, the Caribbean, and Europe. This is an important component of our global expansion strategy as Marley Naturals is one of our most popular brands, growing 210% compared to Q3 2019, and we are extremely pleased to bring these products to customers in new markets. We remain committed to pursuing opportunities for channel expansion and digital solutions as we continue to see a high number of customers utilizing online shopping to meet their retail demands. Online sales grew 196% for Q3 2020 compared to Q3 2019. And we anticipate that many customers who were driven online due to the ongoing pandemic will remain online shoppers when the pandemic ends. We continue to look for opportunities to improve our digital platform and create a global best-in-class customer experience. Turning to the numbers, revenue for the quarter was $35.8 million, a sequential increase of 10% compared with Q2 2020, while gross profit was approximately $2.5 million or 6.9% of net sales. Bill will address this further in his discussion. However, I would like to note that excluding the impact of certain inventory adjustments, which were recorded in response to strategic management decisions during the quarter, gross profit would have otherwise been $7.3 million or 20.4% of net sales. As always, I want to finish by sincerely thanking our team for all their dedicated hard work as we continue to successfully execute on our strategic goals amid a challenging macro environment. We have made significant progress year-to-date on our transformational growth initiatives, and we look forward to ending the year solidly and entering 2021 on strong footing. With that, I will now turn it over to Bill to run through our third quarter 2020 financial results in further detail.

Thanks, Aaron, and hello, everyone. As a reminder, the results I will be reviewing for you this morning can be found on our earnings release. Before I begin my review of our third quarter financials, I want to provide some additional color on the improvements we have made and are continuing to make to the company. Since speaking with you last quarter, we have made substantial progress on our business transformation plan with a new COO, President, and CFO. We worked throughout August and September to craft the pathway that we anticipate will bring the business to profitability in 2021. We made strategic decisions to pivot away from certain lines of business to increase inventory velocity, margins, and turns. We also focused on swiftly selling down these deemphasized lines to generate cash, allowing us to reinvest in more profitable third-party inventory and our own health brands. While these decisions had a negative financial impact on Q3 2020, these actions were necessary to put the company on the right course for future revenue growth and profitability. As part of our efforts to improve the financial profile of the company, we reduced worldwide staff by 4.5% in October and are implementing additional expense reductions between now and the end of Q1 2021. These reductions along with the margin-enhancing direction in inventory and sales focus will save an annualized $5 million per year. This is in addition to the $1 million of savings that we discussed on our Q2 call. With all of these recent initiatives, we believe our path to return to adjusted EBITDA profitability in Q1 2021 is well underway. Net sales for Q3 2020 were $35.8 million compared to $44.9 million for the third quarter of 2019, a decrease of $9.1 million or 20.3%. This decrease was the result of the impact of our business transformation and strategic decisions made to reduce our low-margin sales. We reduced our sales of nicotine products to $3.3 million or 9.2% of net sales for the third quarter 2020 compared to $20.2 million or 45% of net sales for the third quarter of 2019. This is an 83% reduction in nicotine-related product sales year-over-year. Looking specifically at our core business lines, Greenlane’s core net sales grew 36% to $32.3 million compared to $23.7 million in Q3 2019. We are extremely excited to see this impact of our strategic vision. Revenues in the United States for Q3 were approximately $29 million compared to approximately $38.6 million in the same period in 2019, representing a decrease of $9.6 million or 24.9%, primarily due to a decrease in nicotine products. Revenues in Canada for the third quarter of 2020 were approximately $4.4 million compared to approximately $6.3 million in the same period in 2019, representing a decrease of $1.8 million or 29.3%. This was primarily due to COVID-19. Our European segment, which we entered last year with the acquisition of Conscious Wholesale in Q3 2019, generated revenues of approximately $2.3 million in Q3. On a sequential basis, Q3 net sales increased 10% from $32.4 million in Q2 2020. In Q3, gross profit was $2.5 million or 6.9% of net sales compared to $6.4 million or 14.3% of net sales in Q3 2019. During the quarter, Greenlane made specific strategic decisions regarding existing inventory levels and go-forward product lines. As a result of those decisions, we decided to sell down certain inventory items, which resulted in adjustments to inventory of $3.2 million. By reducing our slow-moving inventory, we preserve warehouse space and working capital for higher-margin products, one of the key goals of our transformation initiative. In addition, a $1.1 million reserve was made for obsolete inventory items, while we also recorded a $500,000 lower of cost or market adjustment related to a notification received from a supplier that they had taken a permanent reduction in their wholesale selling price of certain items. As Aaron mentioned, excluding the impact of these one-time inventory adjustments, Q3 2020 gross margin would otherwise have been 20.4%. This results in a gross margin improvement of 610 basis points compared to Q3 2019. Also, we incurred inefficiencies related to transitioning our warehouses that amounted to approximately 150 basis points of margin, suggesting further opportunity. I expect overall gross margin to expand from its current levels as we execute on our strategic vision, with Greenlane brands at the core. Salaries, benefits, and payroll taxes in Q3 2020 decreased approximately $1.6 million to $5 million or 23.8% compared to Q3 2019, primarily due to a decrease in equity-based compensation expense of $2.5 million as the Company recognized a net reversal of stock comp expense of approximately $1 million during Q3 as compared to $1.5 million of stock comp expense in Q3 2019. G&A costs for the third quarter of 2020 increased approximately $5.9 million to $10.7 million compared to $4.8 million in Q3 of 2019, primarily due to a loss of $2.2 million related to a portion of an indemnification asset. This was a one-time expense. The remainder is due to an increase of approximately $900,000 in subcontractor fees, an increase of approximately $1 million in third-party logistics expenses related to additional expenses incurred as we consolidated our distribution centers in the U.S. and Canada, an increase of $800,000 in allowances for uncollectible vendor deposits incurred in connection with management’s strategic initiatives to improve inventory turnover, and an increase of approximately $500,000 in restructuring costs. Net loss for Q3 2020 was $13.8 million compared to $9 million in Q3 2019. Adjusted net loss was $6.9 million in Q3 2020 compared to $7.5 million adjusted net loss for Q3 2019. Adjusted EBITDA loss was $6.3 million in Q3 compared to adjusted EBITDA loss of $3.4 million in Q3 2019. The increase in adjusted EBITDA loss this quarter was primarily driven by an increase in G&A costs of $3.7 million in Q3 2020 as compared to Q3 2019, which increased overall net loss for the current period, along with a provision for income tax expense of approximately $11 million recorded in Q3 2019 related to a full valuation allowance recorded against our deferred tax asset in the prior year. This amount represented a positive adjustment to derive adjusted EBITDA loss in Q3 2019. We remain well-funded with $40 million of cash as of September 30, 2020, compared to $47.8 million in cash as of December 31, 2019. Year-to-date, our cash used in operating activities was $3.8 million, as compared to $33.5 million last year. This is an 89% improvement in cash utilization. With a renewed focus on efficiently managing our cash balance, we have improved our financial stability and have the flexibility to leverage our balance sheet to execute on growth initiatives while also pursuing potential M&A opportunities. With that, I will turn the call back to the operator and open it up for Q&A.

Good morning. I just like to start with the inventory adjustment that you guys took in the quarter. We talked about this last quarter. It seems like last quarter was a one-time item and now we have got another inventory issue, which sounds like it is more related to our strategic review. So hoping to get more clarity on what changed in the quarter please? Thanks.

Actually, Vivien, this is Bill Mote. I will take that question. Vivien, we, in the third quarter, obviously, we brought several new management members into the group. As a team, we spent a good 60-days reviewing the entire business strategy. We, as a new management team, had a bit of a different perspective on what inventory turns should be, what the quality of inventory should be, and the velocity of certain SKU items. From there, we made decisions about what we wanted to do going forward. One of our key aspects of our strategy is to continue to conserve our cash. We wanted to be able to move some of these inventory items a lot faster than they were actually moving on the balance sheet. So we did make a strategic decision to reduce the selling price of certain items so that we could get the velocity up and the cash back into the company. Our inventory turns are less than 1.5% at this point in time, historically. We believe, as the management team, that needs to be higher than 3%. So there is a lot of work to do there. But the first step is setting in motion a rapid inventory sale for items that are either deemphasized or that we are no longer going forward with. So that was the crux of the decision process to reduce inventory further.

That is really helpful, Bill. Thank you for that color. And then just my follow-up on your outlook to get back to EBITDA positive, adjusted EBITDA positive in the first quarter of 2021. Certainly, it is nice to see a quarter of 2021. Certainly, it is nice to see a sequential improvement in your top line, and I understand the $5 million in run rate cost savings from headcount reductions and other efficiencies. But can you help dimension what kind of revenue base you need to generate the appropriate operating leverage to actually get to that positive adjusted EBITDA target in 1Q 2021, please? Thanks.

I think it is going to be in the low 40s, Vivien. We are going to need to be - on an annualized basis, in the low 40s on a quarter basis to achieve that.

Good morning and thanks for the questions here. Can you provide a little bit of color on the DTC segment and kind of maybe normalizing that level from the third quarter after the post-COVID here? We saw a meaningful pickup during the shelter in place. And what has kind of you guys expect the ordering pattern or the growth on the DTC side here as we normalize opening up the economy here?

Yes, great question, Scott. Nice to speak to you as well. So obviously, a tremendous lift on a year-over-year basis, as we had described in previous quarters. We saw the early indications, obviously, in late Q1, but really saw a tremendous uplift in the DTC. That remains relatively sustained; it has come down on a sequential basis a little bit as brick-and-mortar has largely reopened. But as we mentioned, on a go-forward basis, we do believe that we will see sustained increased levels of DTC. It will be very interesting to see what impacts COVID may have as we continue through Q4 and into Q1. I know, obviously, all of us are well aware of the increase in COVID cases, and we are even seeing some lockdowns in international countries and watching that very closely. But again, it is great to have an Omni-distribution channel where we have these different revenue channels to drive sales from. So we will watch it closely to see how COVID may impact that. Overall, we do expect an increased sustained level of direct-to-consumer going forward. As we mentioned before, we are in the low teens as a percentage of total revenue, and we do anticipate that trend to continue at a minimum.

Great, thanks for that color. And then kind of a follow-up on your strategic initiatives here as far as your own stores, higher standard brick-and-mortar kind of rollout potentially in Europe. And then you are well-positioned with $40 million in cash. Kind of how are you guys looking at potential expansion from the store side and what is the M&A opportunity that you guys are looking at from a European side? It seems that is where you want the global growth to continue to grow.

Sure. So I will start with the question about the brick-and-mortar stores. In a COVID environment, I will tell you, especially, we are being very, very cautious around brick-and-mortar stores. Obviously, there has been tremendous negative impact to many stores, brick-and-mortar stores around the world during the pandemic. We did reopen our brick-and-mortar stores back in July for the most part. But as of right now, especially during the COVID environment, we do not have any near or midterm plans to expand our physical brick-and-mortar footprint. Again, we will continue to analyze as we continue to go through the pandemic and life begins to normalize in the future, but we have no near or midterm plans to expand that footprint. On the M&A side of things, we continue to have a very robust pipeline of potential opportunities that I will let Bill speak more to as well. But generally speaking, at the height of the pandemic, we went into capital preservation mode and were very cautious as no one really knew what the true impacts of COVID would be. Now that we have a better sense of that, we have reinvigorated and reengaged a number of potential M&A opportunities and conversations.

Yes, and that is primarily the reason we are conserving our cash to make sure that we have plenty of dry powder to execute on those acquisitions to help augment our organic revenue and margins.

Hi, thanks for taking the questions. So curious, a little more color on gross margin and you have a lot of factors that are should be helping gross margin over time, the in-house brands, the direct-to-consumer, the supply packaging, all growing segments all higher margins. Can you give us a sense of how we should think about for next year is like a mid-20s number feel right for you? And then remind us if the in-house brand margins are still holding up from where they were a couple of quarters ago or a year ago or so. And maybe you can give us some more color on kind of what is driving that growth is it new product introductions, do you have more new products coming out of the pipe or just some color around that would be great.

Yes. So gross margins adjusted are 20.4%. And I also mentioned on the call that we had about 150 basis points of what I would call the noise in the margin related to the inefficiencies we had as we transitioned multiple warehouses into one centralized U.S. warehouse and the Canadian warehouse. So you take those two things together, 20.4 plus another 150 basis points gets very close to 22%. Our expectation is for that 20.4% plus level to exist in the near future. Obviously, as we continue to convert more of our revenue, which we said on the call, 36% of the growth in Greenlane or core products, as we continue to convert to our Greenlane brands, we will see that margin increase. So our guidance - while we don’t give a lot of future guidance, we are definitely confirming or reaffirming that the 20 plus margin area is where we will be in the short term, which we feel nice and confident about. Related to just Greenlane brand margins, on a year-over-year or quarter-over-quarter basis, they continue to be strong. Some of the growth that you mentioned for next year is going to come from products that we have already released in terms of product lines, but also from new product development that is being created out there. We do see strong revenues in the VIBES area and we feel that will continue into next year. VIBES, as we have mentioned before, has a very strong margin profile.

Yes. And to follow on with Bill’s comments there, we are seeing tremendous growth in our Greenlane brands. This is the existing brands. We are seeing continued growth in the products we have already launched. We do have a robust pipeline of additional products that we would be launching in the near and mid-term. But definitely, a lot of the growth overall of Greenlane brands that we are seeing thus far is just the growth of the brands themselves. And we called out a couple of examples like Marley Natural, 210% quarter-over-quarter growth. VIBES, 202% quarter-over-quarter growth. Year-to-date, VIBES is up 628%, as an example. So we are seeing tremendous growth numbers and trajectory in our existing Greenlane brands. We will supplement that growth with an additional launch of new products that we are very excited about.

I would say Greenlane brands was 36%. It was actually 65% growth in Greenlane brands compared to last year at the same time. So as you can see, it is a considerable amount of growth in continued trajectory.

Alright. Kind of related, I guess. But in the last couple of years, there has been a lot of noise around the quarters because of all the JUUL stuff and everything. But is there a seasonal effect in Q4, do you see like a bump in product revenue from the holiday season?

Historically, we do see a seasonally adjusted positive increase in overall revenues that is tied, generally speaking to the cooler months of the year, in particular, the holidays as well. But oftentimes, we see that trend continue into Q1. So we do anticipate a seasonal lift to revenues.

Great. And last one for me. Can you just give us more color on the outlook for the packaging business? Just kind of what some of the dynamics of what is going on there. And that is it for me. Thanks.

Yes. The packaging business, again, in conjunction with a lot of the leadership changes that we made at the senior leadership level, we made some changes to senior leadership in the packaging division. We do anticipate a steady growth trajectory for the packaging business. We decided, again, similar to what Bill had mentioned before in supply and packaging. We did deemphasize certain lines of business that were somewhat legacy at this point and reemphasize and refocus on some of the hotter products that we have and new innovative products that we continue to launch. So all that in, I would consider let's say steady growth into 2021 and beyond is really what we are focused on.

Yes. Thanks and good morning guys. In terms of the restructuring that you guys have been going through, is there anything still significant that you need to clean up or fix or working on that you want to highlight?

Well, we continue to work on our overall distribution and logistics. That big chunk of that was done in the U.S., and we have to look at that all over the world to make sure we are doing that efficiently. We continue to look for any mechanisms to reduce other expenses including some of the work that we have already done on our global headcount, which we announced that we reduced 4.5% in October. So those are the areas that we have focused on historically and continue to focus on. In addition, in the margin area, as I said, some of the work that we have done to improve the overall logistics and warehousing has caused temporarily an increase in cost there, which ultimately will diminish as we get lined out with all of the new warehouses and we are operating at 100% efficiency. So those are kind of the areas we are always focused on the entire P&L, and anything that we can do to make things more efficient or less expensive, we will continue to do so.

But overall, we have spent a tremendous amount of energy and effort as an executive team in Q3. Again, a lot of new senior leadership to the team. So a heightened amount of activity in Q3. We will always look to ways to continue to improve our operational efficiency and increase our margin profile and sales. But yes, an unusually high amount of activity in Q3. While we continue to make incremental improvement, we do not expect to see that type of activity going forward.

Got it. It sounds like you are over the hump there. So, did you guys push hard in e-commerce, you saw a lot of growth there or was that just sort of a natural effect of COVID and whatnot? How do we think about that going forward?

It is a combination of both. I mean, obviously, we have a dedicated team of e-commerce experts that is constantly pushing the envelope in terms of the customer experience and driving new customers and existing customers to our sites. But definitely, COVID was a positive windfall in terms of consumer purchasing patterns and behaviors. So frankly, it is the combination of those two. As we said before, we do anticipate an increased sustained level of online purchasing behavior to continue even post-pandemic which is why we are making additional strategic investments in our e-commerce and other digital assets going forward.

Got it. And then maybe just lastly. Nicotine sales, does that remain low single-digit for a while? Or do you see that going away? How should we think about modeling that into 2021?

Another great question. So I would say the best way to characterize that is that we do anticipate it to continue in a single-digit fashion on a go-forward basis. Well, again, continuously evaluate that in terms of potentially just eliminating that. But frankly, our job here, we really want to make sure that we are meeting our customers’ needs. And as of today, nicotine products do represent an important component of our customer product lines. So we do anticipate to continue to carry those products. But again, the historical deemphasis on nicotine products has driven our overall concentration down. We will continue to maintain those product lines for the foreseeable future. As an important part of a broader portfolio to our customers and meeting our customers’ needs. But it will maintain a lower percentage of revenue. The only caveat to that is there is potential opportunity just on the short term, maybe Q4, as we had mentioned, kind of reducing the selling prices of certain inventory items. Some of that does include nicotine products. So we are in the process of selling down some of those inventory items that we have so that we can increase our overall inventory turns on a go-forward basis. So mid-single-digit go-forward basis, but maybe a one-time uplift in Q4.

Got it. Thank you.

At this time, I’m showing no further questions. I would like to turn the call back over to Aaron LoCascio for closing remarks.

Yes. I just want to say thank you again for everyone for joining Greenlane’s conference call today. The replay for this conference call will be available in approximately two hours on Greenlane’s website in the Investor Relations section. I hope everyone has a wonderful day.

Thank you.

Ladies and gentlemen, this concludes today’s conference call. Thank you for participating. You may now disconnect.